StockData
argenx SE logo

argenx SE (ARGX) stock

ARGXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 19, 2026Score 5/30
$925.70−16.34 (-1.73%)

Close on Nov 20, 2026Market cap –P/E 47.3Yield –

argenx net income

Net income is the profit left for shareholders after every expense, interest and tax.

For fiscal 2025 it was $1.29B, up 55.1% from the year before. The highest annual figure on record is $1.29B in fiscal 2025.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.29B+55.1%
FY2024Dec 31, 2024$833.04M–
FY2023Dec 31, 2023-$295.05M–
FY2022Dec 31, 2022-$709.59M–
FY2021Dec 31, 2021-$408.27M–
FY2020Dec 31, 2020-$608.46M–

More argenx figures

See a number that looks wrong?